Author:
Thibonnier M.,Holford N. H. G.,Upton R. A.,Blume C. D.,Williams R. L.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics
Reference27 articles.
1. A. Karim, C. Nissen, and D. L. Azarnoff. Clinical pharmacokinetics of disopyramide.J. Pharmacokin. Biopharm. 10:465–494 (1982).
2. B. Whiting, N. H. G. Holford, and L. B. Sheiner. Quantitative analysis of the disopyramide concentration effect relationship.Eur. J. Clin. Pharmacol. 9:67–75 (1980).
3. S. M. Bryson, B. Whiting, and J. R. Lawrence. Disopyramide serum and pharmacologic effect kinetics applied to the assessment of bioavailability.Br. J. Clin. Pharmacol. 6:409–419 (1978).
4. J. J. Lima, H. Boudoulas, and M. Blanford. Concentration dependence of disopyramide binding to plasma protein and its influence on kinetics and dynamics.J. Pharmacol. Exp. Ther. 219:741–747 (1981).
5. G. W. Holt, R. L. G. Norris, P. J. Ravenscroft, J. H. N. Bett, L. G. Dryburgh, and C. M. Boyle. Effect of disopyramide on left ventricular performance: The relationship of free and total concentrations of the drug and of its mono-N-dealkylated metabolite to noninvasive indices of function.J. Cardiovasc. Pharmacol. 5:51–54 (1983).
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献